Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Bayer
 More »

  • Scaleup Issues for Single Use and Steel
    L. Going the Other Way Technicians at Bayer Healthcare's Berkeley, CA facility, which ... development scientist, both of whom work at Bayer Healthcare on antibody development. ...
    10-15-2013
  • Novartis Inks Agreement for ImmunoGen's "TAP" ADC Technology
    ImmunoGen said it has four wholly owned clinical-stage product candidates and additional compounds in clinical phases through collaborations with Amgen, Bayer HealthCare, Biotest, ...
    10-11-2013
  • Takeover Targets: Who Is First on the List?
    ... by FDA in 2012. Regeneron collaborates with Bayer HealthCare on development of Eylea. ... biopharmas-including giants like AbbVie, Bayer, Genentech, GSK, and Pfizer-which have ...
    9-24-2013
  • JobWatch: Praying for a Massachusetts Miracle
    Bayer HealthCare consolidates in NJ; BMS lands a new Florida home. Think of biopharma ... Bayer Healthcare: No Tarry-ing Out of NY Bayer HealthCare will shut down by month's end ...
    9-18-2013
  • Genzyme's MS Drug Lemtrada Receives EU Authorization
    in MS, Bayer HealthCare retains an option to co-promote the drug in MS, and has told Genzyme of its intention to co-promote under this option. Bayer would receive ...
    9-17-2013
  • Bayer, Broad on Five-Year Mission to Search for Novel Cancer...
    Bayer HealthCare and the Broad Institute are joining forces in the area of oncogenomics ... Bayer will have an option for an exclusive license for therapeutic agents at preclinical ...
    9-10-2013
  • As Big Deals Resurface, Who's Next to the Altar?
    ... He cited the company's antibody-drug conjugate licensing agreements with 12 biopharmas-including giants such as AbbVie, Bayer, Genentech, GlaxoSmithKline, and Pfizer-that have ...
    9-9-2013
  • Spreading Sunshine on What Biopharma Pays Physicians
    ... ProPublica has tallied more than $2 billion from 15 biopharmas since 2009. Until the Sunshine Act, some drug giants including Amgen, Bayer, Sanofi, and Roche disclosed no payment ...
    8-29-2013
  • Amgen Grows Cancer Holdings with $10.4B Onyx Acquisition
    Nexavar is an oral kinase inhibitor of Onyx and Bayer HealthCare Pharmaceuticals , and is co-developed by the companies except in Japan where Bayer manages all development. The ...
    8-26-2013
  • Bayer Collaboration Could Net $540M+ for Compugen
    Bayer HealthCare will team up with Compugen on preclinical research toward antibody-based ... targets discovered by Compugen, with Bayer exercising full control over further ...
    8-5-2013
  • Drug Candidates on Trial
    ... The current trial is to be a randomized, double-blind study designed to assess the safety of ORMD-0801. Hemophilia A > Bayer HealthCare started to enroll patients in an ...
    7-22-2013
  • Top 15 Pharma Companies of 2013
    five were ranked for the first time (Bayer, Eli Lilly, Takeda, Astellas, and Daiichi ... 18.7% Position on 2012 List: #9 #8. Bayer 2013 Market Cap: $87.527 billion (3/31: ...
    7-19-2013
  • Evotec Scores $1.9M Boehringer Milestone Payday
    BI is one of several drug developers with which Evotec has long-term discovery alliances; the others include Bayer, CHDI, Genentech, Janssen Pharmaceuticals, MedImmune/AstraZeneca, ...
    7-8-2013
  • High-Tech Academic Centers Look to Milk Their Cash Cows
    ... weeks, Bayer HealthCare and Roche have agreed to work with QB3 startups, joining two other pharma giants that partner with the institute on that and other initiatives. Bayer ...
    7-1-2013
  • Onyx Spurns Amgen Offer, Pursues Its Own Deal
    Some 80% of that revenue came from two drugs co-marketed with Bayer HealthCare Pharmaceuticals: Nexavar (sorafenib) tablets for hepatocellular carcinoma (HCC), which is the most ...
    7-1-2013
  • More »

    Journal Articles

  • Evaluation of a New Blood Glucose Monitoring System with Auto...
    Charles Kilo, Mary Pinson, Judy Ostrom Joynes, Hal Joseph, Nanette Monhaut, Joan Lee Parkes, John Baum
    Diabetes Technology & Therapeutics
    Background: The Ascensia® CONTOUR(tm) System (Bayer HealthCare LLC, Elkhart, IN) is a new ... with the Ascensia MICROLET VACULANCE® (Bayer), for use with samples obtained from four ...
  • Chemistry of Seawater Neutralization of Bauxite Refinery Residues...
    Colleen Hanahan, David McConchie, John Pohl, Robert Creelman, Malcolm Clark, Curt Stocksiek
    Environmental Engineering Science
    Chemistry of Seawater Neutralization of Bauxite Refinery Residues (Red Mud) Environmental Engineering Science Bayer process red muds are highly alkaline, and their disposal and ...
  • Chemistry of the Acid Neutralization Capacity of Bauxite Residue
    Sameer Khaitan, David A. Dzombak, Gregory V. Lowry
    Environmental Engineering Science
    Environmental Engineering Science Abstract Bauxite residue (red mud-RM), a byproduct of the Bayer process for refining bauxite to alumina, is highly alkaline (pH?~?13) and its ...
  • Evaluation of a Glucose Meter in Determining the Glycemic Index...
    Fenghua Sun, Stephen H. Wong, Yajun Chen, Yajun Huang
    Diabetes Technology & Therapeutics
    Abstract Background: The purpose of this study was to evaluate whether the Glucometer Elite® meter (Bayer Diagnostics, Kyoto, Japan) (POG) could be used for determining the ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll